Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 15;8(9):15423-31.
eCollection 2015.

In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents

Affiliations

In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents

Hui Pang et al. Int J Clin Exp Med. .

Abstract

Rapidly growing mycobacteria (RGM) are human pathogens that are relatively easily identified by acid-fast staining but are proving difficult to treat in the clinic. In this study, we performed susceptibility testing of 40 international reference RGM species against 20 antimicrobial agents using the cation-adjusted Mueller-Hinton (CAMH) broth microdilution based on the minimum inhibitory concentration (MIC) assay recommended by the guidelines of the Clinical and Laboratory Standards Institute (CLSI). The results demonstrated that RGM organisms were resistant to the majority of first-line antituberculous agents but not to second-line fluoroquinolones or aminoglycosides. Three drugs (amikacin, tigecycline and linezolid) displayed potent antimycobacterial activity against all tested strains. Capreomycin, levofloxacin and moxifloxacin emerged as promising candidates for the treatment of RGM infections, and cefoxitin and meropenem were active against most strains. Mycobacterium chelonae (M. chelonae), M. abscessus, M. bolletii, M. fortuitum, M. boenickei, M. conceptionense, M. pseudoshottsii, M. septicum and M. setense were the most resistant RGM species. These results provide significant insight into the treatment of RGM species and will assist optimization of clinical criteria.

Keywords: Drug susceptibility; antimicrobial; minimum inhibitory concentration (MIC); rapidly growing mycobacteria (RGM); reference strains.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Susceptibility of 40 reference rapidly growing mycobacteria to 20 selected antimicrobial agents.
Figure 2
Figure 2
Susceptibility of the Mycobacterium abscessus group to 20 selected antibacterial agents.
Figure 3
Figure 3
Susceptibility of the Mycobacterium fortuitum group to 20 selected antibacterial agents.
Figure 4
Figure 4
Susceptibility of the Mycobacterium smegmatis group to 20 selected antibiotics.

References

    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. - PubMed
    1. Jang MA, Koh WJ, Huh HJ, Kim SY, Jeon K, Ki CS, Lee NY. Distribution of nontuberculous mycobacteria by multigene sequence-based typing and clinical significance of isolated strains. J Clin Microbiol. 2014;52:1207–1212. - PMC - PubMed
    1. Griffith DE. Mycobacterium abscessus subsp abscessus lung disease: ‘trouble ahead, trouble behind’. F1000Prime Rep. 2014;6:107. - PMC - PubMed
    1. Preece CL, Perry A, Gray B, Kenna DT, Jones AL, Cummings SP, Robb A, Thomas MF, Brodlie M, O’Brien CJ, Bourke SJ, Perry JD. A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis. J Cyst Fibros. 2015 [Epub ahead of print] - PubMed
    1. Gray TJ, Kong F, Jelfs P, Sintchenko V, Chen SC. Improved Identification of Rapidly Growing Mycobacteria by a 16S-23S Internal Transcribed Spacer Region PCR and Capillary Gel Electrophoresis. PLoS One. 2014;9:e102290. - PMC - PubMed

LinkOut - more resources